Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...
Risk for HF hospitalization and all-cause mortality are reduced in patients with HFrEF that have digitoxin added to guideline-directed therapy.
San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...
Heart failure (HF) imposes a large and growing burden on the population, with a prevalence that is projected to increase to more than 8 million adults by 2030. The high risk of morbidity and mortality ...
In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...
PUMPING FOR LIFE: Ejection fraction is a measure of how much blood your heart is pumping. With each heartbeat, the heart contracts and relaxes. As it contracts, the left and right ventricles eject ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results